West Family Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$930K Sell
5,931
-272
-4% -$40.8K 0.27% 63
2026
Q1
$948K Sell
6,203
-6,519
-51% -$999K 0.33% 50
2025
Q4
$1.75M Sell
12,722
-198
-2% -$25.9K 0.41% 40
2025
Q3
$1.66M Buy
12,920
+154
+1% +$18.8K 0.37% 48
2025
Q2
$1.54M Buy
12,766
+2,757
+28% +$311K 0.4% 41
2025
Q1
$1.12M Hold
10,009
0.42% 45
2024
Q4
$974K Buy
10,009
+270
+3% +$28.8K 0.34% 58
2024
Q3
$1.12M Buy
9,739
+1,927
+25% +$219K 0.38% 55
2024
Q2
$832K Sell
7,812
-57
-0.7% -$5.72K 0.25% 73
2024
Q1
$761K Buy
7,869
+284
+4% +$29.1K 0.24% 79
2023
Q4
$766K Buy
7,585
+144
+2% +$13.9K 0.26% 76
2023
Q3
$758K Sell
7,441
-961
-11% -$97.5K 0.26% 74
2023
Q2
$848K Buy
8,402
+562
+7% +$56.2K 0.33% 66
2023
Q1
$721K Buy
7,840
+94
+1% +$8.21K 0.29% 74
2022
Q4
$703K Sell
7,746
-4,142
-35% -$349K 0.24% 75
2022
Q3
$904K Buy
11,888
+2,563
+27% +$212K 0.38% 60
2022
Q2
$788K Buy
+9,325
New +$818K 0.31% 63
2021
Q4
Sell
-15,458
Closed -$1.26M 363
2021
Q3
$1.26M Buy
15,458
+3,413
+28% +$307K 0.33% 51
2021
Q2
$1.1M Buy
+12,045
New +$1.07M 0.3% 49

Other funds holding NVS

West Family Investments's NVS Position: Q2 2026 in Review

West Family Investments reduced its Novartis (NVS) stake by 4.4% in Q2 2026, selling an estimated $40.8K and leaving 5,931 shares worth $930K. The position accounts for 0.27% of the portfolio, ranked #63.

West Family Investments first reported a position in NVS in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.75M in Q4 2025. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • West Family Investments held 5,931 shares of Novartis worth $930K as of Q2 2026.
  • West Family Investments sold 272 Novartis shares in Q2 2026, an estimated $40.8K.
  • Novartis made up 0.27% of West Family Investments's portfolio in Q2 2026, its #63 holding.
  • West Family Investments first reported a position in Novartis in Q2 2021 and has held it in 19 quarters since.
  • West Family Investments's Novartis position peaked at $1.75M in Q4 2025.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.